ArticleOncogene2020
CRMP2 is a therapeutic target that suppresses the aggressiveness of breast cancer cells by stabilizing RECK.
Binyan Lin et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
13 papers cite it
this papercites it
ArticleOncogene2020
Binyan Lin et al.PubMed ↗Publisher ↗
No numbers read from the abstract.